This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of bioactive molecules and drug candidates. Its structure, featuring a tert-butoxycarbonyl (Boc) protected pyrrolidine ring and a benzoic acid group, makes it a valuable building block in organic synthesis. It is often employed in the preparation of compounds targeting neurological disorders, as the pyrrolidine moiety is a common feature in molecules interacting with central nervous system receptors. Additionally, it serves as a precursor in the creation of peptidomimetics, which are used to mimic peptide structures for drug design. The Boc group provides stability during synthetic processes and can be selectively removed under mild conditions, allowing for further functionalization. Its application extends to the development of protease inhibitors and other therapeutic agents, making it a versatile tool in medicinal chemistry.